Satellos Bioscience Management
Management criteria checks 0/4
Satellos Bioscience's CEO is Frank Gleeson, appointed in Mar 2018, has a tenure of 6.67 years. total yearly compensation is CA$1.93M, comprised of 20.7% salary and 79.3% bonuses, including company stock and options. directly owns 3.37% of the company’s shares, worth CA$2.87M. The average tenure of the management team and the board of directors is 1.5 years and 2.9 years respectively.
Key information
Frank Gleeson
Chief executive officer
CA$1.9m
Total compensation
| CEO salary percentage | 20.7% |
| CEO tenure | 6.7yrs |
| CEO ownership | 3.4% |
| Management average tenure | 1.5yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Is Satellos Bioscience (TSE:MSCL) In A Good Position To Deliver On Growth Plans?
Oct 07
We're Hopeful That Satellos Bioscience (TSE:MSCL) Will Use Its Cash Wisely
Apr 11Here's Why We're Not Too Worried About Satellos Bioscience's (CVE:MSCL) Cash Burn Situation
Dec 22Will Satellos Bioscience (CVE:MSCL) Spend Its Cash Wisely?
Apr 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -CA$29m |
| Jun 30 2024 | n/a | n/a | -CA$23m |
| Mar 31 2024 | n/a | n/a | -CA$21m |
| Dec 31 2023 | CA$2m | CA$398k | -CA$16m |
| Sep 30 2023 | n/a | n/a | -CA$14m |
| Jun 30 2023 | n/a | n/a | -CA$13m |
| Mar 31 2023 | n/a | n/a | -CA$11m |
| Dec 31 2022 | CA$338k | CA$260k | -CA$11m |
| Sep 30 2022 | n/a | n/a | -CA$9m |
| Jun 30 2022 | n/a | n/a | -CA$18m |
| Mar 31 2022 | n/a | n/a | -CA$17m |
| Dec 31 2021 | CA$1m | CA$226k | -CA$16m |
| Sep 30 2021 | n/a | n/a | -CA$13m |
| Jun 30 2021 | n/a | n/a | -CA$2m |
| Mar 31 2021 | n/a | n/a | -CA$2m |
| Dec 31 2020 | CA$192k | CA$192k | -CA$2m |
| Dec 31 2019 | CA$180k | CA$180k | -CA$2m |
Compensation vs Market: Frank's total compensation ($USD1.38M) is above average for companies of similar size in the Canadian market ($USD169.13K).
Compensation vs Earnings: Frank's compensation has increased whilst the company is unprofitable.
CEO
Frank Gleeson (69 yo)
6.7yrs
Tenure
CA$1,926,547
Compensation
Mr. Francis Gleeson, also known as Frank, B.B.A., M.B.A., is a Co-Founder of Satellos Bioscience Inc. He serves as Chief Executive Officer of Satellos Bioscience Inc. since March 2018. He serves as Directo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 6.7yrs | CA$1.93m | 3.37% CA$ 2.9m | |
| CFO & Corporate Secretary | 1.2yrs | CA$741.42k | 0.035% CA$ 30.1k | |
| Chief Scientific Officer | 1.8yrs | CA$1.45m | no data | |
| Executive Director | 3.3yrs | CA$216.74k | 1.51% CA$ 1.3m | |
| Head of Corporate Strategy | 1.2yrs | CA$444.38k | no data | |
| Chief Business Officer | 1.2yrs | CA$745.80k | 0.0037% CA$ 3.2k | |
| Co-Founder & Chief Discovery Officer | no data | CA$120.00k | 2.73% CA$ 2.3m | |
| Senior Vice President of Finance & Administration | 3.2yrs | no data | 0.071% CA$ 60.1k | |
| Strategic Advisor | 3.3yrs | CA$44.48k | no data | |
| Chief of Staff | no data | no data | no data | |
| Senior Vice President of Clinical Development Operations | less than a year | no data | no data | |
| Senior Vice President of Medical & Scientific Affairs | less than a year | no data | no data |
1.5yrs
Average Tenure
63yo
Average Age
Experienced Management: MSCL's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 12.3yrs | CA$1.93m | 3.37% CA$ 2.9m | |
| Executive Director | 3.3yrs | CA$216.74k | 1.51% CA$ 1.3m | |
| Independent Director | 1.4yrs | CA$47.41k | 6.67% CA$ 5.7m | |
| Independent Chairman of the Board of Directors | 6.3yrs | CA$87.84k | 0.22% CA$ 191.2k | |
| Independent Director | 3.3yrs | CA$68.27k | 0.022% CA$ 18.8k | |
| Independent Director | 6.7yrs | no data | 1.3% CA$ 1.1m | |
| Independent Director | 2.9yrs | CA$93.58k | no data | |
| Chair of Clinical Advisory Board & Chief Medical Advisor | less than a year | no data | no data | |
| Member of Clinical Advisory Board | less than a year | no data | no data | |
| Independent Director | 2.9yrs | CA$69.28k | no data | |
| Member of Clinical Advisory Board | less than a year | no data | no data | |
| Member of Clinical Advisory Board | less than a year | no data | no data |
2.9yrs
Average Tenure
62yo
Average Age
Experienced Board: MSCL's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.